FDA Investigator Jennifer L Jager

Jennifer L Jager has conducted inspections on 132 sites in 2 countries as of 23 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
23 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100005490
Countries of Inspections:
United States of America, Germany
FDA Investigators that have inspected at least one site in common with Jennifer L Jager:
Alan Escalona, Alec M O'neal, Alexander M Kay, Allison C Hunter, Allison E Sincek, Allison M Scheck, Amy A Johnson, Ana Djurdjevic, Andrew I Carr, Andrew M Kupper, Andrew T Todd, Andria L Kuhlman, Anna M Brannen, Arie R Dyk, Asad Ali, Bailey A Uetrecht, Benjamin D Shuler, Blyss L Ketterer, Brandon L Mariner, Brenda C Hamilton, Brigitte K Hofmann, Bryan J Love, Bryce A May, Carlos H Ruiz, Cassandra L Winters, Catherine D Djordjevic, Ching Jeyg Chang, Christian L Witkovskie, Christina L Bigham, Christine E Kelley, Christopher T Middendorf, Craig P Seaborn, Craig T Rybus, Cynthia A Harris, MD, RN, Cynthia L Rakestraw, Cynthia T Cain, D'arbra R Blankenship, Darren S Morgan, David P Moorhead, Dell S Moller, Diane R Mcdaniel, Donna F Campbell, Dorathy M Eischen, Doretha M Tonkins, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dyanthony T Jenkins, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emma A Nesbit, Garrad R Poole, Genevieve E Ghand, Geoffrey K Kilili, Gerald Mierle, Gordon R Davidson, Holly J Rapier, Holly J Wilson, Hugh M Mcclure, II, James G Marsh, James Murphey, Jason D Werne, Jennifer L Gustavus, Jennifer L Sheehan, Jessica M Wooten, John D Jaworski, John E Russell, Jr, Jonathan A Ferguson, Joseph X Kaufman, Joshua C Schafer, Joshua S Hunt, Karen M Cooper, Karen M Kondas, Kathleen D Culver, Kathryn J Mccarty, Kathryn Suttling, Keith J Mason, Jr, Kelli L Wilkinson, Kelly D Moore, Kenneth L Smalls, Kimberly A Joseph, Kirk A Dymbrowski, Laine P Myers, Laressa R Gray, Laureen M Geniusz, Lauren N Smith, LCDR Wilfred A Darang, Leena Thomas, Leslie R Clark, Linda S Mattingly, Lindsey M Schwierjohann, Logan T Williams, Luckner Jean Marie, Malik S Qaiser, Maney P Sturgill, Marcia A Worley, Marianne Allen, Maribeth G Niesen, Marion W Nadeau, Mark E Parmon, Mary B Sheets, Mary T Carden, Matt D Suedkamp, Matthew B Casale, Meredith M Cobb, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael I Gorman, Michael J Schibi, Michael K Larson, Michael P Sheehan, Nadeem I Chaudhry, Nancy L Neiger, Nicholas L Paulin, Nisha C Patel, Phillip M Pontikos, Pifer, Richard J Bashay, Richard W Berning, Robert Rodriguez, Rosanna M Goodrich, Roy C Stephens, Said H Muse, Samuel A Hamblin, Sean R Moynihan, MPH, Shannon A Gregory, Sherry L Secrist, BLT DO, Stephen J Rabe, Steven P Eastham, Susan M Taylor, Tamara M Kays, Teresa K Kastner, Thomas B Smith, Thomas C Woods, Thomas J Prigge, Thomas W Nojek, Thunder N Dunkijacobs, Tracey L Harris, Travis R Hunt, Troy A Huffman, Wen Ning Chan (Sally), Yvette Mlacour Davis

Jennifer L Jager's Documents

Publish Date Document Type Title
April, 2013 EIR David J. Portman M.D. - EIR, 2013-04-11
October, 2014 FDA 483 Manisha H Shah, M.D. - Form 483, 2014-10-17
March, 2011 FDA 483 Anthony Grote - Form 483, 2011-03-30
April, 2013 EIR David J. Portman M.D. - EIR, 2012-10-26
October, 2014 EIR Manisha H Shah, M.D. - EIR, 2014-10-17
January, 2013 EIR Hoxworth Blood Center University of Cincinnati - EIR, 2013-01-07
February, 2014 EIR Michael J Noss MD - EIR, 2014-02-20
June, 2014 EIR LifeNet Health - EIR, 2014-06-09
January, 2013 FDA 483 Nationwide Children's Hospital IRB - Form 483, 2013-01-25
January, 2013 FDA 483 Hoxworth Blood Center University of Cincinnati - Form 483, 2013-01-07
June, 2011 FDA 483 Joe Siefring - Form 483, 2011-06-30
March, 2012 FDA 483 Wright State University IRB - Form 483, 2012-03-15
January, 2013 EIR Nationwide Children's Hospital IRB - EIR, 2013-01-25
April, 2013 FDA 483 David J. Portman M.D. - Form 483, 2012-10-26
February, 2011 FDA 483 Miami Valley Hospital-Irb - Form 483, 2011-02-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more